BR Biomedical Reports 2049-9434 2049-9442 D.A. Spandidos 10.3892/br.2017.1004 BR-0-0-1004 Articles Human aqueous humor levels of transforming growth factor-β2: Association with matrix metalloproteinases/tissue inhibitors of matrix metalloproteinases JiaYan 1 2 * YueYu 1 * HuDan-Ning 3 ChenJi-Li 4 ZhouJi-Bo 1 Department of Ophthalmology, Shanghai Ninth People's Hospital, Shanghai Jiaotong University, School of Medicine, Shanghai 200011, P.R. China Department of Ophthalmology, Children's Hospital of Fudan University, Shanghai Fudan University, School of Medicine, Shanghai 201102, P.R. China Departments of Ophthalmology and Pathology, New York Eye and Ear Infirmary of Mount Sinai, New York, NY 10003, USA Department of Ophthalmology, Shibei Hospital, Shanghai 200435, P.R. China Correspondence to: Professor Ji-Bo Zhou, Department of Ophthalmology, Shanghai Ninth People's Hospital, Shanghai Jiaotong University, School of Medicine, 500 Quxi Road, Huangpu, Shanghai 200011, P.R. China, E-mail: zhoujibo1000@aliyun.com Dr Ji-Li Chen, Department of Ophthalmology, Shibei Hospital, 4500 Gonghexin Road, Jingan, Shanghai 200435, P.R. China, E-mail: corneachen@163.com

Contributed equally

 12 2017 20 10 2017 7 6 573 578 02062017 29092017 Copyright © 2017, Spandidos Publications 2017

The present study aims to investigate the association of transforming growth factor-β2 (TGF-β2) and matrix metalloproteinases (MMPs), MMP-2 and MMP-3, and tissue inhibitors of matrix metalloproteinases (TIMPs), TIMP-1, TIMP-2 and TIMP-3 in the aqueous humor of patients with high myopia or cataracts. The levels of TGF-β2 and MMPs/TIMPs were measured with the Luminex xMAP Technology using commercially available Milliplex xMAP kits. The association between TGF-β2 and MMPs/TIMPs levels was analyzed using the Spearmans correlation test. The levels of TGF-β2 were identified to be positively correlated with the levels of TIMP-1 and TIMP-3 (TIMP-1: r=0.334; P=0.007; TIMP-3: r=0.309; P=0.012). The levels of MMP-2, MMP-3 and TIMP-2 did not significantly correlate with TGF-β2 levels (P>0.05). A positive correlation was identified between TGF-β2 and TIMPs in the aqueous humor of human eyes with elongated axial length. It appears that TGF-β2 stimulates the expression of TIMPs as a compensatory reaction to the development of high myopia.

 high myopia aqueous humor transforming growth factor-β2 matrix metalloproteinases tissue inhibitors of matrix metalloproteinases correlation study Introduction

Myopia is becoming more prevalent in China. High myopia has many serious complications that may lead to severe vision impairment. During the development of myopia, there is a loss of extracellular matrix (ECM), which may cause sclera remolding and axial elongation (1). Despite the changes in scleral ECM that occur during mammalian myopia development, there is relatively little understanding of the cellular and signaling factors that drive such changes. Increasing evidence has indicated that the retina and other relevant ocular tissues may synthesize and secrete transforming growth factor-β2 (TGF-β2) to regulate the remodeling of the sclera (2–5), which may result in myopia development. TGF-β has been demonstrated in vitro to induce matrix metalloproteinases (MMPs) production from fibroblasts by interfering with the Smad and mitogen-activated protein kinases (MAPK) signaling pathways (6). MMPs are a family of enzymes that are capable of triggering the decomposition of scleral ECM components, the activities of which are regulated by physiological inhibitors, known as tissue inhibitors of matrix metalloproteinases (TIMPs) (7–13). TGF-β2, MMPs and TIMPs are key in the progression of ECM degradation during the pathological processes of myopia (14–17). To the best of our knowledge, the correlation between TGF-β2 and MMPs/TIMPs in human aqueous humor in myopic patients has not previously been reported. Recently, TGF-β2 and MMP/TIMP levels in the aqueous humor were evaluated in 65 patients with high myopia or cataract and it was identified that the TGF-β2 and MMP/TIMP levels in the aqueous humor of patients with high myopia were significantly different from patients with cataract (17,18). As a follow up study of our published studies (17,18), the aim of the present study was to use the data (17,18) to analyze the correlation between TGF-β2 and MMP/TIMP levels in the aqueous humor from these patients.

 Materials and methods <sec> <title>Patients and samples

The subjects and methods used for the measurement of multiple factors in the current study have been reported previously (17,18). The previous studies included two groups of patients as follows: High myopia (35 cases) and cataract (30 cases). High myopia was defined as patients (with or without cataract) with refraction <-6 D (35 cases, 35 eyes). Cataract cases included cataract patients with a range of different refractive statuses; including emmetropia, hyperopia and myopia, with the exception of high myopia (30 cases, 30 eyes).

Specimens were obtained at the beginning of the clear lens extraction or cataract extraction surgery to avoid the breakdown of the blood-aqueous barrier associated with surgical manipulation. A 30-gauge needle attached to a tuberculin microsyringe was used to aspirate the aqueous humor from the central pupillary area without touching the iris, lens, or corneal endothelium with the needle to avoid trauma and the contamination of the aqueous humor specimens by various tissue components or blood. Specimens were stored immediately below −80°C until analysis (17,18).

All samples were assayed for total protein levels of TGF-β2, MMP-1, −2, −3, TIMP-1, −2, and −3 using a Luminex system (Luminex xMAP Technology, Bio-Rad Laboratories, Inc., Hercules, CA, USA) and commercially available Milliplex xMAP kits (TGFB-64K-03, HMMP2MAG-55K-02, HMMP1MAG-55K-01, HTMP2MAG-54K-03; EMD Millipore, Billerica, MA, USA) (17–20).

All patients signed informed consent and the study was approved by the Institutional Review Board at the Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine (Shanghai, China) (17,18).

 Analysis of the association between TGF-β2 and TIMPs

The association between the levels of TGF-β2 and various MMPs/TIMPs (MMP-2, MMP-3, TIMP-1, TIMP-2 and TIMP-3) was analyzed separately by evaluating the significance of the correlation coefficient between various groups.

 Statistical analysis

The original data were not normally distributed according to the Kolmogorov-Smirnov test. Therefore, the results were expressed as medians and ranges (25th and 75th percentiles) using continuous variables that are not normally distributed, such as the levels of TGF-β2 and TIMPs, or as a mean (standard deviation) for normally distributed continuous variables, such as age. The association between TGF-β2 and TIMPs was analyzed using Spearmans correlation test. SPSS 22.0 software for Windows (IBM Corp., Armonk, NY, USA) was used to perform these analyses. A two-tailed P<0.05 was considered to indicate a statistically significant difference.

 Results <sec> <title>Analysis of the levels of MMPs, TIMPs and TGF-β2

Briefly, the average age of the 65 patients was 67.0±11.7 years, comprising of 29 males and 36 females (17). Among the 65 subjects, 30 eyes had cataracts and 35 eyes were highly myopic (all in the stationary stage). The results of the levels of TGF-β2 and TIMPs were published in our previous papers (17,18), which revealed that MMP-1 was not detected and TGF-β2, MMP-2, MMP-3, TIMP-1, TIMP-2 and TIMP-3 were detected in the aqueous humor. The levels of TGF-β2, MMP-2, TIMP-1, TIMP-2, TIMP-3 in the high myopia group were significantly higher than those in the cataract eyes group, while MMP-3 levels in the high myopia group were not statistically higher than that in the cataract eyes group.

 Correlation of TGF-β2 with MMPs

In the present study, the correlation between the levels of TGF-β2 and different MMPs/TIMPs in the aqueous humor specimens was analyzed by Spearmans correlation test. The TGF-β2 level was not identified to be significantly correlated with the MMP-2 level (P>0.05), although the levels of the two increased in the aqueous humor (Fig. 1). Furthermore, the levels of TGF-β2 were also not significantly correlated with the levels of MMP-3 (P>0.05; Fig. 2).

 Correlation of TGF-β2 with TIMPs

A significantly positive correlation was identified between the levels of TGF-β2 and TIMP-1 (r=0.334, P=0.007; Fig. 3), and with TGF-β2 and TIMP-3 (r=0.309, P=0.012; Fig. 4). However, no significant correlation was observed between the levels of TGF-β2 and TIMP-2 (P>0.05; Fig. 5).

 Discussion

In the current study, the associations between TGF-β2 and MMPs/TIMPs in the aqueous humor of myopia and cataract patients were analyzed, with the aim of highlighting the role of TGF-β2 and MMPs/TIMPs in the development of myopia.

TGF-β2 is an important factor in the modulation of growth and development of the eyeball (21). In four-week-old guinea pigs, it was demonstrated that the retinal levels of the TGF-β2 protein are highly correlated with ocular refraction and axial length (22). TGF-β2 is a key factor in the progression of myopia development and axial elongation; however, reports of its expression in experimental myopia have been controversial as animal studies have demonstrated increases and decreases (22–26). It appears that the changes in TGF-β2 expression during the development of myopia are species- and tissue-specific (22–24,25,27). Our previous study (18) and the study by Zhuang et al (28) found that TGF-β2 levels were increased in the aqueous or vitreous humor in stationary high myopia patients with axial elongation (18,28).

TIMPs are a group of endogenous specific inhibitors of the activity of various MMPs, and the balance between MMPs/TIMPs regulates ECM turnover and remodeling during normal development and pathogenesis (11). Animal studies have revealed that the levels of MMPs increased during the development period of myopia (29,30). Our previous study (17) and the study by Zhuang et al (28) identified that aqueous MMP-2 and −3 levels increased in ocular specimens during the stationary stage of high myopia patients (17,28). TIMPs inhibit the degradation of ECM, which is caused by MMPs. Therefore, it is expected that during various physiological or pathological processes that involve the degradation of the ECM, TIMP levels decrease and are associated with increased levels of MMPs; these changes lead to degradation of the ECM (8,10–12). However, under certain circumstances the levels of TIMPs do not decrease, they increase (8,10–13,31–45). These contradictory changes of TIMP have been explained by the homeostasis hypothesis, that is, the elevation of TIMP levels reflects a cellular compensatory reaction to counteract and limit the intensive degradation of ECM by MMPs. In this case, the TIMP expression levels should increase rather than decrease (11–13,40,41,46,47).

In animal studies of myopia, the changes of TIMP levels during the development period of myopia are complicated; it has been reported that the levels of TIMP mRNA in the scleral increase (14,48), decrease (49,50) or do not change significantly (49,50). During the recovery stage of experimental myopia, the MMP-2 levels invariably decrease, and the TIMP levels usually increase (29,30,50,51).

Our previous studies revealed that the levels of TIMPs in the aqueous humor increased during the stationary stage of high myopia patients (17). This may be explained by the homeostasis hypothesis; the elevation in TIMP levels reflects a cellular compensatory reaction to counteract the degradation of ECM by MMPs.

Little is known regarding the molecular mechanism of this compensatory response of increased levels of TIMPs in myopia. The present study has demonstrated that the increase of TIMP-1 and TIMP-3 in the aqueous humor of high myopia patients was positively correlated with the increase of TGF-β2 levels, indicating that TGF-β2 may be the molecule that causes the increase in TIMP expression levels in high myopia. This is consistent with previous reports demonstrating that TGF-β2 increased the levels of TIMP-1 in human RPE cells (52), and the upregulation of TIMP by TGF-βs in human, rat or bovine chondrocytes and fibroblasts (53–58).

The signaling pathways of TGF-β-induced TIMP expression in myopia have not been investigated systematically; however, they has been evaluated in human and experimental animal fibroblasts and chondrocytes (53,54,59).

Morris et al (59) demonstrated that TGF-β increased the levels of the TIMP-3 protein in human cartilage, but did not significantly affect the expression levels of TIMP-3 mRNA (59). Wang et al (53) observed that TGF-β induces TIMP-3 expression in rat chondrocytes via activation of the extracellular signal-regulated kinase (ERK)1/2 and Smad2/3 signaling pathways. Leivonen et al (54) identified that TGF-β induced TIMP-3 mRNA expression in mouse and human fibroblasts. This effect was abolished by the inhibition of ERK1/2 activation and p38 mitogen-activated protein kinase (p38 MAPK), indicating that ERK1/2 and p38 MAPK mediate the effect of TGF-β on TIMP-3 expression levels. Furthermore, Smad3 co-operated with p38 MAPK and ERK1/2 in the induction of TIMP-3 expression. The study demonstrated that TGF-β induces TIMP-3 expression via a complex interplay between Smad3, p38, and ERK1/2 signaling (54).

The present analysis revealed that the levels of TGF-β2 were positively correlated with the levels of TIMP-1 and TIMP-3, but were not associated with the levels of TIMP-2. This may be relevant to the different effects of various TIMPs on the expression levels of MMP; TIMP-1 and −3 are inhibitors of various MMPs. TIMP-2 is an inhibitor of MMPs, as well as an activator for pro-MMP-2. Furthermore, TIMP-2 binds to latent MMP-2 and MT1-MMP at the cell surface, resulting in proteolytic activation of the latent MMP-2 by adjacent MT1-MMP (7–9,11). It has been reported that at high concentrations, TIMP-2 causes inhibition; however, at low concentrations it increases the activities of MMP-2 (8,11). This may provide an explanation for the different associations between TGF-β and various TIMPs.

It has been reported that TGF-βs may influence the expression level of MMPs (6). However, in the present study, the levels of MMPs in the aqueous humor in cataract or high myopia eyes were not identified to be correlated with TGF-β2 levels. Therefore, the results of the present analysis indicate that in human high myopia, the effects of TGF-β2 on the pathogenesis of myopia may be via the modulation of TIMP expression levels rather than by MMP expression levels. However, the present study was based on the analysis of factors in the aqueous humor during the stationary stage of myopia, therefore, the results should be interpreted cautiously.

In conclusion, the present analysis has revealed that an increase in the levels of TIMPs in the aqueous humor in the stationary stage of human high myopia patients was positively correlated with the increase in TGF-β2 levels. The elevation of TIMP expression levels most likely reflects a cellular compensatory reaction to counteract and limit the intense degradation of the ECM by MMPs. TGF-β2 is possibly one of the molecules that is involved in the modulation of this process. However, the cause-effect association between the increase in TGF-β and TIMP levels in the development of myopia and its mechanism requires further investigation.

 Acknowledgements

The current study was supported by the National Nature Science Foundation of China (grant no. 81371050) and the Shanghai Municipal Commission of Health and Family Planning Fund (grant no. 201440354).

 References ChenBYWangCYChenWYMaJXAltered TGF-β2 and bFGF expression in scleral desmocytes from an experimentally-induced myopia guinea pig modelGraefes Arch Clin Exp Ophthalmol25111331144201310.1007/s00417-013-2269-823381656 HodosWKuenzelWJRetinal-image degradation produces ocular enlargement in chicksInvest Ophthalmol Vis Sci2565265919846724835 NagineniCNCherukuriKSKuttyVDetrickBHooksJJInterferonamma differentially regulates TGF-β1 and TGF-β2 expression in human retinal pigment epithelial cells through JAK-STAT pathwayJ Cell Physiol210192200200710.1002/jcp.2083917013806 SekoYTanakaYTokoroTScleral cell growth is influenced by retinal pigment epithelium in vitroGraefes Arch Clin Exp Ophthalmol232545552199410.1007/BF001819987959094 TroiloDNicklaDLMertzJRSummersRada JAChange in the synthesis rates of ocular retinoic acid and scleral glycos-aminoglycan during experimentally altered eye growth in marmosetsInvest Ophthalmol Vis Sci4717681777200610.1167/iovs.05-029816638980 AsanoKShikamaYShojiNHiranoKSuzakiHNakajimaHTiotropium bromide inhibits TGF-β-induced MMP production from lung fibroblasts by interfering with smad and MAPK pathways in vitroInt J Chron Obstruct Pulmon Dis5277286201010.2147/COPD.S1173720856827 MurphyGNagaseHProgress in matrix metalloproteinase researchMol Aspects Med29290308200810.1016/j.mam.2008.05.00218619669 KahariVSaarialho-KereUMatrix metalloproteinases and their inhibitors in tumour growth and invasionAnn Med313445199910.3109/0785389990901926010219712 BrewKDinakarpandianDNagaseHTissue inhibitors of metalloproteinases: evolution, structure and functionBiochim Biophys Acta1477267283200010.1016/S0167-4838(99)00279-410708863 GroblewskaMSiewkoMMroczkoBSzmitkowskiMThe role of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in the development of esophageal cancerFolia Histochem Cytobiol501219201210.5603/FHC.2012.000222532131 ChircoRLiuXWJungKKKimHRNovel functions of TIMPs in cell signalingCancer Metastasis Rev2599113200610.1007/s10555-006-7893-x16680576 EgebladMWerbZNew functions for the matrix metalloproteinases in cancer progressionNat Rev Cancer2161174200210.1038/nrc74511990853 SternlichtMDWerbZHow matrix metalloproteinases regulate cell behaviorAnnu Rev Cell Dev Biol17463516200110.1146/annurev.cellbio.17.1.46311687497 McBrienNAGentleARole of the sclera in the development and pathological complications of myopiaProg Retin Eye Res22307338200310.1016/S1350-9462(02)00063-012852489 GaoHFrostMRSiegwartJTJrNortonTTPatterns of mRNA and protein expression during minus-lens compensation and recovery in tree shrew scleraMol Vis17903919201121541268 SheltonLRadaJSEffects of cyclic mechanical stretch on extracellular matrix synthesis by human scleral fibroblastsExp Eye Res84314322200710.1016/j.exer.2006.10.00417123515 JiaYHuDNZhuDZhangLGuPFanXZhouJMMP-2, MMP-3, TIMP-1, TIMP-2, and TIMP-3 protein levels in human aqueous humor: relationship with axial lengthInvest Ophthalmol Vis Sci5539223928201410.1167/iovs.14-1398324876280 JiaYHuDNZhouJHuman aqueous humor levels of TGF- β2: relationship with axial lengthBiomed Res Int2014258591201410.1155/2014/25859124967344 ManiseMHoltappelsGVan CrombruggenKSchleichFBachertCLouisRSputum IgE and cytokines in asthma: relationship with sputum cellular profilePLoS One8e58388201310.1371/journal.pone.005838823555579 CodicesVMartinsCNovoCde SousaBLopesÂBorregoMMatosODynamics of cytokines and immunoglobulins serum profiles in primary and secondary Cryptosporidium parvum infection: usefulness of Luminext xMAP technologyExp Parasitol133106113201310.1016/j.exppara.2012.11.00323178641 BajracharyaDShresthaBKamathAMenonARadhakrishnanRImmunohistochemical correlation of matrix metalloproteinase-2 and tissue inhibitors of metalloproteinase-2 in tobacco associated epithelial dysplasiaDis Marker2014197813201410.1155/2014/197813 SekoYShimokawaHTokoroTExpression of bFGF and TGF-beta 2 in experimental myopia in chicksInvest Ophthalmol Vis Sci361183118719957730028 HondaSFujiiSSekiyaYYamamotoMRetinal control on the axial length mediated by transforming growth factor-beta in chick eyeInvest Ophthalmol Vis Sci372519252619968933768 McBrienNARegulation of scleral metabolism in myopia and the role of transforming growth factor-betaExp Eye Res114128140201310.1016/j.exer.2013.01.01423399866 JoblingAINguyenMGentleAMcBrienNAIsoform-specific changes in scleral transforming growth factor-β expression and the regulation of collagen synthesis during myopia progressionJ Biol Chem2791812118126200410.1074/jbc.M40038120014752095 EstellaCHerrerIAtkinsonSPQuiñoneroAMartínezSPellicerASimónCInhibition of histone deacetylase activity in human endometrial stromal cells promotes extracellular matrix remodelling and limits embryo invasionPLoS One7e30508201210.1371/journal.pone.003050822291969 JoblingAIWanRGentleABuiBVMcBrienNARetinal and choroidal TGF-β in the tree shrew model of myopia: isoform expression, activation and effects on functionExp Eye Res88458466200910.1016/j.exer.2008.10.02219046968 ZhuangHZhangRShuQJiangRChangQHuangXJiangCXuGChanges of TGF-β2, MMP-2, and TIMP-2 levels in the vitreous of patients with high myopiaGraefes Arch Clin Exp Ophthalmol25217631767201410.1007/s00417-014-2768-225112847 GuggenheimJAMcBrienNAForm-deprivation myopia induces activation of scleral matrix metalloproteinase-2 in tree shrewInvest Ophthalmol Vis Sci371380139519968641841 SiegwartJTJrNortonTTSelective regulation of MMP and TIMP mRNA levels in tree shrew sclera during minus lens compensation and recoveryInvest Ophthalmol Vis Sci4634843492200510.1167/iovs.05-019416186323 ChaveyCMariBMonthouelMNBonnafousSAnglardPVan ObberghenETartare-DeckertSMatrix metalloproteinases are differentially expressed in adipose tissue during obesity and modulate adipocyte differentiationJ Biol Chem2781188811896200310.1074/jbc.M20919620012529376 LimayeAMDesaiKVChavalmaneAKKondaiahPRegulation of mRNAs encoding MMP-9 and MMP-2, and their inhibitors TIMP-1 and TIMP-2 by androgens in the rat ventral prostateMol Cell Endocrinol2941018200810.1016/j.mce.2008.07.00318675881 MaDHChenJKKimWSHaoYXWuHCTsaiRJHwangDGZhangFExpression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinase 1 and 2 in inflammation-induced corneal neovascularizationOphthalmic Res33353362200110.1159/00005569311721189 WebbKEHenneyAMAnglinSHumphriesSEMcEwanJRExpression of matrix metalloproteinases and their inhibitor TIMP-1 in the rat carotid artery after balloon injuryArterioscler Thromb Vasc Biol1718371844199710.1161/01.ATV.17.9.18379327785 LakatosGHritzIVargaMZJuhászMMihellerPCiernyGTulassayZHerszényiLThe impact of matrix metalloproteinases and their tissue inhibitors in inflammatory bowel diseasesDig Dis30289295201210.1159/00033699522722554 GomezDEDe LorenzoMSAlonsoDFAndradeZAExpression of metalloproteinases (MMP-1, MMP-2, and MMP-9) and their inhibitors (TIMP-1 and TIMP-2) in schistosomal portal fibrosisAm J Trop Med Hyg61913199910.4269/ajtmh.1999.61.910432047 KnittelTMehdeMGrundmannASaileBScharfJGRamadoriGExpression of matrix metalloproteinases and their inhibitors during hepatic tissue repair in the ratHistochem Cell Biol113443453200010933221 FigueiraRCGomesLRNetoJSSilvaFCSilvaIDSogayarMCCorrelation between MMPs and their inhibitors in breast cancer tumor tissue specimens and in cell lines with different metastatic potentialBMC Cancer920200910.1186/1471-2407-9-2019144199 GressTMMüller-PillaschFLerchMMFriessHBuchlerMAdlerGExpression and in-situ localization of genes coding for extracellular matrix proteins and extracellular matrix degrading proteases in pancreatic cancerInt J Cancer62407413199510.1002/ijc.29106204097635566 PorukKEFirpoMAScaifeCLAdlerDGEmersonLLBoucherKMMulvihillSJSerum osteopontin and tissue inhibitor of metalloproteinase 1 as diagnostic and prognostic biomarkers for pancreatic adenocarcinomaPancreas42193197201310.1097/MPA.0b013e31825e354d23407481 GardnerJGhorpadeATissue inhibitor of metalloproteinase (TIMP)-1: the TIMPed balance of matrix metalloproteinases in the central nervous systemJ Neurosci Res74801806200310.1002/jnr.1083514648584 SinghRDHaridasNPatelJBShahFDShuklaSNShahPMPatelPSMatrix metalloproteinases and their inhibitors: correlation with invasion and metastasis in oral cancerIndian J Clin Biochem25250259201010.1007/s12291-010-0060-821731196 WallardMJPenningtonCJVeerakumarasivamABurttGMillsIGWarrenALeungHYMurphyGEdwardsDRNealDEKellyJDComprehensive profiling and localisation of the matrix metalloproteinases in urothelial carcinomaBr J Cancer94569577200610.1038/sj.bjc.660293116465195 KossakowskaAEHuchcroftSAUrbanskiSJEdwardsDRComparative analysis of the expression patterns of metalloproteinases and their inhibitors in breast neoplasia, sporadic colorectal neoplasia, pulmonary carcinomas and malignant non-Hodgkins lymphomas in humansBr J Cancer7314011408199610.1038/bjc.1996.2668645587 MaJWangJFanWPuXZhangDFanCXiongLZhuHXuNChenRLiuSUpregulated TIMP-1 correlates with poor prognosis of laryngeal squamous cell carcinomaInt J Clin Exp Pathol7246254201324427345 YlisirniöSHöyhtyäMTurpeenniemi-HujanenTSerum matrix metalloproteinases −2, −9 and tissue inhibitors of metalloproteinases −1, −2 in lung cancer - TIMP-1 as a prognostic markerAnticancer Res2013111316200010810441 MooreCSCrockerSJAn alternate perspective on the roles of TIMPs and MMPs in pathologyAm J Pathol1801216201210.1016/j.ajpath.2011.09.00822033229 McBrienNACornellLMGentleAStructural and ultrastructural changes to the sclera in a mammalian model of high myopiaInvest Ophthalmol Vis Sci4221792187200111527928 RadaJABrenzaHLIncreased latent gelatinase activity in the sclera of visually deprived chicksInvest Ophthalmol Vis Sci361555156519957601636 RadaJAPerryCASloverMLAchenVRGelatinase A and TIMP-2 expression in the fibrous sclera of myopic and recovering chick eyesInvest Ophthalmol Vis Sci4030913099199910586929 SchippertRBrandCSchaeffelFFeldkaemperMPChanges in scleral MMP-2, TIMP-2 and TGFβ-2 mRNA expression after imposed myopic and hyperopic defocus in chickensExp Eye Res82710719200610.1016/j.exer.2005.09.01016289164 EichlerWFriedrichsUThiesATratzCWiedemannPModulation of matrix metalloproteinase and TIMP-1 expression by cytokines in human RPE cellsInvest Ophthalmol Vis Sci4327672773200212147614 WangXZhuYTaoHJinCLiuYLuXHuXFanCInteraction of ERK1/2 and Smad2/3 signaling pathways in TGF-β1-induced TIMP-3 expression in rat chondrocytesArch Biochem Biophys564229236201410.1016/j.abb.2014.09.00925245272 LeivonenSKLazaridisKDecockJChantryAEdwardsDRKähäriVMTGF-β-elicited induction of tissue inhibitor of metalloproteinases (TIMP)-3 expression in fibroblasts involves complex interplay between Smad3, p38α, and ERK1/2PLoS One8e57474201310.1371/journal.pone.005747423468994 NarcisiRQuartoRUliviVMuragliaAMolfettaLGiannoniPTGF β-1 administration during ex vivo expansion of human articular chondrocytes in a serum-free medium redirects the cell phenotype toward hypertrophyJ Cell Physiol22732823290201210.1002/jcp.2402422105490 LunaJMasamuntMCLlachJDelgadoSSansMPalm oil tocotrienol rich fraction reduces extracellular matrix production by inhibiting transforming growth factor-β1 in human intestinal fibroblastsClin Nutr30858864201110.1016/j.clnu.2011.07.00121807443 TodorovaLGürcanEWestergren-ThorssonGMiller-LarssonABudesonide/formoterol effects on metalloproteolytic balance in TGFβ-activated human lung fibroblastsRespir Med10317551763200910.1016/j.rmed.2009.03.01819375904 SuSGroverJRoughleyPJDiBattistaJAMartel-PelletierJPelletierJPZafarullahMExpression of the tissue inhibitor of metalloproteinases (TIMP) gene family in normal and osteoarthritic jointsRheumatol Int18183191199910.1007/s00296005008310399794 MorrisKJCs-SzaboGColeAACharacterization of TIMP-3 in human articular talar cartilageConnect Tissue Res51478490201010.3109/0300820100368695820388016

Correlation between aqueous TGF-β2 and MMP-2 levels. TGF-β2 and MMP-2 levels in the aqueous humor from 65 patients with myopia or cataract during cataract or clear lens extraction surgery were measured with Luminex xMAP Technology using commercially available Milliplex xMAP kits. Spearmans correlation test demonstrated that TGF-β2 was not correlated with MMP-2 (P>0.05). TGF-β2, transforming growth factor-β2; MMP-2, matrix metalloproteinase-2.

Correlation between aqueous TGF-β2 and MMP-3 levels. TGF-β2 and MMP-3 levels in the aqueous humor from 65 patients with myopia or cataract during cataract or clear lens extraction surgery were measured with the Luminex xMAP Technology using commercially available Milliplex xMAP kits. Spearmans correlation test demonstrated that TGF-β2 was not correlated with MMP-3 (P>0.05). TGF-β2, transforming growth factor-β2; MMP-2, matrix metalloproteinase-2.

Correlation between aqueous TGF-β2 and TIMP-1 levels. TGF-β2 and TIMP-1 levels in the aqueous humor from 65 patients with myopia or cataract during cataract or clear lens extraction surgery were measured with the Luminex xMAP Technology using commercially available Milliplex xMAP kits. Spearmans correlation test demonstrated that TGF-β2 was positively correlated with TIMP-1 (r=0.334; P=0.007). TGF-β2, transforming growth factor-β2; TIMP-1, tissue inhibitors of matrix metalloproteinase-1.

Correlation between aqueous TGF-β2 and TIMP-3 levels. TGF-β2 and TIMP-3 levels in the aqueous humor from 65 patients with myopia or cataract during cataract or clear lens extraction surgery were measured with the Luminex xMAP Technology using commercially available Milliplex xMAP kits. Spearmans correlation test showed that TGF-β2 was positively correlated with TIMP-3 (r=0.309; P=0.012). TGF-β2, transforming growth factor-β2; TIMP-3, tissue inhibitors of matrix metalloproteinase-3.

Correlation between aqueous TGF-β2 and TIMP-2 levels. TGF-β2 and TIMP-2 levels in the aqueous humor from 65 patients with myopia or cataract during cataract or clear lens extraction surgery were measured with the Luminex xMAP Technology using commercially available Milliplex xMAP kits. Spearmans correlation test demonstrated that TGF-β2 was not correlated with TIMP-2 (P>0.05). TGF-β2, transforming growth factor-β2; TIMP-2, tissue inhibitors of matrix metalloproteinase-2.